Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Genetics

  Free Subscription


Articles published in Nat Rev Drug Discov

Retrieve available abstracts of 11 articles:
HTML format



Single Articles


    November 2023
  1. KINGWELL K
    Microbial 'dark matter' yields new antibiotic.
    Nat Rev Drug Discov. 2023;22:872.
    PubMed    


    September 2023
  2. XIE W, Chen B, Wong J
    Genomic medicines: the coming waves?
    Nat Rev Drug Discov. 2023;22:691-692.
    PubMed    


    June 2023
  3. VAN DE SANDE B, Lee JS, Mutasa-Gottgens E, Naughton B, et al
    Applications of single-cell RNA sequencing in drug discovery and development.
    Nat Rev Drug Discov. 2023;22:496-520.
    PubMed     Abstract available


    May 2023
  4. VERMA M, Ozer I, Xie W, Gallagher R, et al
    The landscape for lipid-nanoparticle-based genomic medicines.
    Nat Rev Drug Discov. 2023;22:349-350.
    PubMed    


    March 2023
  5. VILLANUEVA MT
    Proteomics reveals small molecules' secrets.
    Nat Rev Drug Discov. 2023;22:181.
    PubMed    


    February 2023
  6. CARSS KJ, Deaton AM, Del Rio-Espinola A, Diogo D, et al
    Using human genetics to improve safety assessment of therapeutics.
    Nat Rev Drug Discov. 2023;22:145-162.
    PubMed     Abstract available


    September 2022
  7. MEISSNER F, Geddes-McAlister J, Mann M, Bantscheff M, et al
    The emerging role of mass spectrometry-based proteomics in drug discovery.
    Nat Rev Drug Discov. 2022;21:637-654.
    PubMed     Abstract available


    August 2022
  8. OCHOA D, Karim M, Ghoussaini M, Hulcoop DG, et al
    Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs.
    Nat Rev Drug Discov. 2022;21:551.
    PubMed    


    May 2022
  9. HEMMERLING F, Piel J
    Strategies to access biosynthetic novelty in bacterial genomes for drug discovery.
    Nat Rev Drug Discov. 2022;21:359-378.
    PubMed     Abstract available


    December 2021
  10. KINGWELL K
    'Bespoke Gene Therapy Consortium' sets out to enable gene therapies for ultra-rare diseases.
    Nat Rev Drug Discov. 2021;20:886-887.
    PubMed    


    November 2020
  11. HOGG SJ, Beavis PA, Dawson MA, Johnstone RW, et al
    Targeting the epigenetic regulation of antitumour immunity.
    Nat Rev Drug Discov. 2020;19:776-800.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Genetics is free of charge.